These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 18598721)
1. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells. Michel PO; Mäkelä AR; Korhonen E; Toivola J; Hedman L; Söderlund-Venermo M; Hedman K; Oker-Blom C J Virol Methods; 2008 Sep; 152(1-2):1-5. PubMed ID: 18598721 [TBL] [Abstract][Full Text] [Related]
2. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors. Lowin T; Raab U; Schroeder J; Franssila R; Modrow S J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399 [TBL] [Abstract][Full Text] [Related]
3. [Preparation of human parvovirus B19 virus-like particles]. Zou X; Dong L; Song J; Qu J; Yu X; Lu Z; Hong T Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):575-9. PubMed ID: 19637634 [TBL] [Abstract][Full Text] [Related]
4. Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles. Gilbert L; Toivola J; White D; Ihalainen T; Smith W; Lindholm L; Vuento M; Oker-Blom C Biochem Biophys Res Commun; 2005 Jun; 331(2):527-35. PubMed ID: 15850791 [TBL] [Abstract][Full Text] [Related]
5. Enhanced kinetic extraction of parvovirus B19 structural proteins. Sico C; White S; Tsao E; Varma A Biotechnol Bioeng; 2002 Nov; 80(3):250-6. PubMed ID: 12226856 [TBL] [Abstract][Full Text] [Related]
6. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. Rosenfeld SJ; Yoshimoto K; Kajigaya S; Anderson S; Young NS; Field A; Warrener P; Bansal G; Collett MS J Clin Invest; 1992 Jun; 89(6):2023-9. PubMed ID: 1376332 [TBL] [Abstract][Full Text] [Related]
7. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773 [TBL] [Abstract][Full Text] [Related]
8. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Kawase M; Momoeda M; Young NS; Kajigaya S Virology; 1995 Aug; 211(2):359-66. PubMed ID: 7544049 [TBL] [Abstract][Full Text] [Related]
9. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen. Heegaard ED; Rasksen CJ; Christensen J J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031 [TBL] [Abstract][Full Text] [Related]
10. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19. Franssila R; Hedman K Vaccine; 2004 Sep; 22(27-28):3809-15. PubMed ID: 15315862 [TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. Pfrepper KI; Enders M; Motz M J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402 [TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. Beersma MF; Claas EC; Sopaheluakan T; Kroes AC J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386 [TBL] [Abstract][Full Text] [Related]
13. Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by Shao S; Wang Q; Jin Y; Zhang X; Liu Z; Chen S; Wu H; Yang S; Tang F; Su J; Liang Y; Zhang J; Li Q Viruses; 2022 Oct; 14(11):. PubMed ID: 36366508 [TBL] [Abstract][Full Text] [Related]
14. Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3. Inoue T; Kawano MA; Takahashi RU; Tsukamoto H; Enomoto T; Imai T; Kataoka K; Handa H J Biotechnol; 2008 Mar; 134(1-2):181-92. PubMed ID: 18243389 [TBL] [Abstract][Full Text] [Related]
15. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma. Li Y; Wang J; Zhu G; Zhang X; Zhai H; Zhang W; Wang W; Huang G Am J Gastroenterol; 2007 Jul; 102(7):1489-98. PubMed ID: 17459020 [TBL] [Abstract][Full Text] [Related]
16. Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose. Ju H; Wei N; Wang Q; Wang C; Jing Z; Guo L; Liu D; Gao M; Ma B; Wang J Biochem Biophys Res Commun; 2011 May; 409(1):131-6. PubMed ID: 21554858 [TBL] [Abstract][Full Text] [Related]
17. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays. Kock WC J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310 [TBL] [Abstract][Full Text] [Related]
18. Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor. Wegner CC; Jordan JA Infect Dis Obstet Gynecol; 2004 Jun; 12(2):69-78. PubMed ID: 15739820 [TBL] [Abstract][Full Text] [Related]
19. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1. Corcoran A; Mahon BP; Doyle S J Infect Dis; 2004 May; 189(10):1873-80. PubMed ID: 15122524 [TBL] [Abstract][Full Text] [Related]
20. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay. Manaresi E; Gallinella G; Zerbini M; Venturoli S; Gentilomi G; Musiani M J Med Virol; 1999 Feb; 57(2):174-8. PubMed ID: 9892404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]